Policy, regulations, AI and CRDMO take centre stage at the flagship event of the Department of Pharmaceuticals
At the centre of this shift is Eli Lilly and Company, whose latest investments in China and Japan are helping redefine the next phase of GLP-1 supply strategy
This event will bring together global stakeholders to explore India’s growing capabilities in pharma and biopharma innovation, research, and manufacturing
No adverse events reported; recall involves 5 mg 500-count bottles in the US market
The two-day conference and exhibition features discussions on policy frameworks, AI-led drug discovery, next-generation technologies, and global competitiveness
Novo Nordisk continues to position Wegovy as a cornerstone of its obesity treatment portfolio
The company says the platform offers improved manufacturability and functional advantages
Discussions are likely to centre on how the country can move up the pharmaceutical value chain
In just the last few days, companies including Lupin, Biocon, Alembic Pharmaceuticals and Aurobindo Pharma have announced approvals for 5 mg and 10 mg tablets, all bioequivalent to Farxiga
Subscribe To Our Newsletter & Stay Updated
